PKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-??,??,??, ?? isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.
More Information Supplier PagePKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-??,??,??, ?? isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePSC-833 is a kind of P-glycoprotein (P-gp) modulator that inhibits P-gp-mediated multidrug-resistance (MDR).
More Information Supplier PageCCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.
More Information Supplier PageCCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier Page
